4//SEC Filing
Farid Marjan 4
Accession 0001415889-22-010936
CIK 0001479419other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:12 PM ET
Size
5.4 KB
Accession
0001415889-22-010936
Insider Transaction Report
Form 4
Farid Marjan
Director
Transactions
- Award
Stock Option (right to buy)
2022-10-31+1,600→ 1,600 totalExercise: $6.35Exp: 2032-10-30→ Common Stock (1,600 underlying)
Footnotes (1)
- [F1]This option was granted on October 31, 2022 and vests with respect to 1/3rd of the shares underlying the option on October 31, 2023 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 31, 2025.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001952098
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:12 PM ET
- Size
- 5.4 KB